Leadership changes, October 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,035
Appointments
576
Departures
68
Browse by role
October 2026
Get new CFO appointments the day the filing lands.
Filters
1,035 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | ENERPAC TOOL GROUP CORP | Charles T. Lauber | directordirector | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | Gen Digital Inc. | Talbott Roche | DirectorDirector | Appointed | Oct 6, 2026 | SEC 8-K |
| Oct 9, 2026 | GOLDENWELL BIOTECH, INC. | Ming Zhou | directordirector | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | GOODYEAR TIRE & RUBBER CO /OH/ | Stephen F. Shamrock | Vice President and ControllerVice President and Controller | Appointed | Oct 16, 2026 | SEC 8-K |
| Oct 9, 2026 | Greystone Housing Impact Investors LP | Robert K. Jacobsen | member of the Committeemember of the Committee | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 9, 2026 | HEALTHEQUITY, INC. | Michael Fiore | Chief Commercial OfficerChief Commercial Officer | Departed | Oct 5, 2026 | SEC 8-K |
| Oct 9, 2026 | Hepion Pharmaceuticals, Inc. | Gary Stetz | Chief Financial OfficerCFO | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 9, 2026 | Hepion Pharmaceuticals, Inc. | Sireesh Appajosyula, PharmD | Chief Executive OfficerCEO | Appointed | Oct 9, 2026 | SEC 8-K |
| Oct 9, 2026 | HUBSPOT INC | Erika Fisher | Chief Legal Officer and Corporate SecretaryCLO | Departed | Nov 6, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Dirk Thye, M.D. | Chief Executive OfficerCEO | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Brendan Hannah | Chief Operating OfficerCOO | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Brigette Roberts, M.D. | Chief Executive OfficerCEO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | John Militello, CPA | Chief Financial OfficerCFO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Keith Fandrick | Chief Operating OfficerCOO | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | June Bray | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | David Lamond | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Christopher Senner | directordirector | Departed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Catherine M. Bonuccelli | Class I director and as a member of the Audit Committee and Compensation CommitteeClass I director and as a member of the Audit Committee and Compensation Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | Leone Patterson | Class III director and as chair of the Audit Committee and as chair of the Compensation CommitteeClass III director and as chair of the Audit Committee and as chair of the Compensation Committee | Appointed | Oct 8, 2026 | SEC 8-K |
| Oct 9, 2026 | IRulya Therapeutics Inc. | James Valentine | Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance CommitteeClass I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee | Appointed | Oct 8, 2026 | SEC 8-K |
- ENERPAC TOOL GROUP CORPAppointed
Charles T. Lauber director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- Gen Digital Inc.Appointed
Talbott Roche Director
Filed Oct 9, 2026Effective Oct 6, 2026SEC 8-K
- GOLDENWELL BIOTECH, INC.Appointed
Ming Zhou director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- GOODYEAR TIRE & RUBBER CO /OH/Appointed
Stephen F. Shamrock Vice President and Controller
Filed Oct 9, 2026Effective Oct 16, 2026SEC 8-K
Robert K. Jacobsen member of the Committee
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
- HEALTHEQUITY, INC.Departed
Michael Fiore Chief Commercial Officer
Filed Oct 9, 2026Effective Oct 5, 2026SEC 8-K
- Hepion Pharmaceuticals, Inc.Appointed
Gary Stetz CFO
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
- Hepion Pharmaceuticals, Inc.Appointed
Sireesh Appajosyula, PharmD CEO
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
- HUBSPOT INCDeparted
Erika Fisher CLO
Filed Oct 9, 2026Effective Nov 6, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Dirk Thye, M.D. CEO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Brendan Hannah COO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Brigette Roberts, M.D. CEO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
John Militello, CPA CFO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Keith Fandrick COO
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
June Bray director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
David Lamond director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Christopher Senner director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Catherine M. Bonuccelli Class I director and as a member of the Audit Committee and Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
Leone Patterson Class III director and as chair of the Audit Committee and as chair of the Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Appointed
James Valentine Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K